← Back to Analyst Consensus 
MDGL Buy
MADRIGAL PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 26
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (8 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Aug 4, 2026 | Wolfe Research | upgrade | Peer Perform → Outperform | — | 53% |
| Aug 3, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 29, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 27, 2026 | Wells Fargo | initiate | — → Overweight | — | 54% |
| Jun 11, 2026 | B of A Securities | maintain | Neutral → Neutral | — | 53% |
| May 13, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| May 7, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| May 7, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| May 6, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Feb 20, 2026 | B of A Securities | maintain | Neutral → Neutral | $529 | 53% |
| Jan 28, 2026 | Barclays | initiate | — → Overweight | $964 | 53% |
| Jan 20, 2026 | Citizens | maintain | Market Outperform → Market Outperform | $745 | 47% |
| Dec 19, 2025 | Piper Sandler | maintain | Overweight → Overweight | $900 | 54% |
| Dec 11, 2025 | B. Riley Securities | maintain | Buy → Buy | $670 | 55% |
| Nov 21, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $620 | 44% |
| Nov 20, 2025 | Oppenheimer | maintain | Outperform → Outperform | $650 | 52% |
| Nov 19, 2025 | Truist Securities | maintain | Buy → Buy | $640 | 54% |
| Nov 13, 2025 | Canaccord Genuity | maintain | Buy → Buy | $587 | 48% |
| Nov 11, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $568 | 44% |
| Nov 5, 2025 | Cantor Fitzgerald | upgrade | Neutral → Overweight | $0 | 50% |
| Nov 5, 2025 | Citizens | maintain | Market Outperform → Market Outperform | $527 | 47% |
| Nov 3, 2025 | B of A Securities | upgrade | Underperform → Neutral | $445 | 53% |
| Oct 15, 2025 | Piper Sandler | maintain | Overweight → Overweight | $540 | 54% |
| Oct 15, 2025 | Truist Securities | initiate | — → Buy | $580 | 54% |
| Oct 10, 2025 | Oppenheimer | maintain | Outperform → Outperform | $590 | 52% |
| Sep 29, 2025 | B. Riley Securities | maintain | Buy → Buy | $560 | 55% |
| Sep 12, 2025 | Canaccord Genuity | maintain | Buy → Buy | $526 | 48% |
| Aug 26, 2025 | TD Cowen | maintain | Buy → Buy | $554 | 54% |
| Aug 20, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $485 | 53% |
| Aug 12, 2025 | UBS | maintain | Buy → Buy | $523 | 54% |
| Aug 6, 2025 | Canaccord Genuity | maintain | Buy → Buy | $428 | 48% |
| May 2, 2025 | UBS | maintain | Buy → Buy | $458 | 54% |
| May 2, 2025 | B. Riley Securities | reiterate | Buy → Buy | $460 | 55% |
| May 2, 2025 | Canaccord Genuity | maintain | Buy → Buy | $420 | 48% |
| Apr 24, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $443 | 53% |
| Feb 27, 2025 | Citigroup | maintain | Buy → Buy | $469 | 54% |
| Feb 27, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $405 | 44% |
| Jan 14, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $400 | 44% |
| Jan 10, 2025 | JMP Securities | reiterate | Market Outperform → Market Outperform | $427 | 53% |
| Nov 20, 2024 | Cantor Fitzgerald | reiterate | — → Neutral | $0 | 50% |
| Nov 5, 2024 | B. Riley Securities | maintain | Neutral → Neutral | $236 | 55% |
| Nov 1, 2024 | UBS | maintain | Buy → Buy | $441 | 54% |
| Oct 23, 2024 | Oppenheimer | maintain | Outperform → Outperform | $350 | 52% |
| Oct 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $390 | 44% |
| Oct 11, 2024 | Cantor Fitzgerald | reiterate | — → Neutral | $0 | 50% |
| Aug 8, 2024 | Citigroup | maintain | Buy → Buy | $371 | 54% |
| Aug 8, 2024 | Evercore ISI Group | maintain | Outperform → Outperform | $360 | 58% |
| Jul 23, 2024 | Cantor Fitzgerald | reiterate | — → Neutral | $0 | 50% |
| Jul 16, 2024 | JMP Securities | maintain | Market Outperform → Market Outperform | $385 | 53% |
Price Target Trend
Jul 10, 2026 Latest: $685.22 Oct 25, 2026
EPS Estimates
+1y $9.63
Lo: $7.01 Hi: $12.84
4 analysts ▲1
0y $-6.49
Lo: $-7.38 Hi: $-4.91
4 analysts +1q $-0.42
Lo: $-0.77 Hi: $0.11
4 analysts 0q $-1.09
Lo: $-1.38 Hi: $-0.56
4 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days